Q4 2024 Allianca Saude e Participacoes SA Earnings Call Transcript
Key Points
- Allianca Saude e Participacoes SA (BSP:AALR3) achieved the highest gross revenue ever recorded by the company, totaling BRL1.3 billion, a 3.5% increase compared to 2023.
- The B2B business unit experienced impressive growth, with a 146% increase in revenue, reaching BRL44 million annually.
- The company recorded an adjusted EBITDA of approximately BRL290 million, the second largest in its history, with an EBITDA margin of 24%.
- Operational efficiency improvements led to a 37% reduction in SG&A expenses in the quarterly comparison and 24% year-on-year.
- Financial leverage ratio was maintained at 2.5 times the net debt adjusted EBITDA, reflecting financial discipline and commitment to sustainability.
- Despite revenue growth, the medical fees line showed a 1%-point increase year-on-year, and a 2%-point increase in the quarterly comparison, due to the expansion of the B2B business line.
- There was a slight increase in medical hospital supplies and services costs in the fourth quarter.
- 40% of the company's total gross debt is short-term, which may pose a risk in a challenging macroeconomic environment.
- The company is operating in a challenging macroeconomic scenario with high interest rates, which could impact future financial performance.
- The company is focused on continuous restructuring and efficiency improvements, which may require ongoing investment and management attention.
Good afternoon, everyone. Thank you for waiting. Welcome to the Allianca fourth quarter earnings release presentation in the conference call for the year of 2024. We will begin the presentation which will be conducted by Mr. Ricardo Sartim, who is the company's Chief Medical Officer and Chief Operating Officer. We also have Mr. Jose Luiz Mendes Ramos with us, who is the Chief Legal Officer and Investor Relations officer. (Operator Instructions)
This conference call will be recorded and will be made available on the company's investor relations website along with the full earnings release materials. Before we get started, we would like to highlight some important notices. We would like to stress that the information presented here, as well as any statements made during the conference regarding business outlook, projections, and operational goals, are assumptions and beliefs by the company's management.
Therefore, they should not be construed as guarantees of future performance. Forward-looking statements involve risks and uncertainties that may or may not become real. Investors must
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
